首页 > 最新文献

Brain Hemorrhages最新文献

英文 中文
Recent trends of treatment strategies and outcomes of basal ganglia hemorrhages at a single institution 一家医疗机构基底节出血治疗策略和疗效的最新趋势
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.hest.2024.03.001
<div><h3>Objective</h3><div>The Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH) Trial was designed to evaluate the minimally invasive <em>trans</em>-sulcal parafascicular surgery (MIPS) approach, a technique advertised for safe access to deep brain structures and ICH removal using the BrainPath® and Myriad® devices (NICO Corporation, Indianapolis, IN). However, basal ganglia hemorrhages (BGHs) were determined to meet the a priori futility rule, resulting in exclusion from further trial enrollment consideration. Since screening for ICH is initiated immediately upon presentation of symptom bearing patients, treatment is curtailed to best preserve remaining neurological function. We sought to determine whether immediate exclusion from consideration of trial enrollment resulted in poorer patient outcomes despite best medical or surgical management.</div></div><div><h3>Methods</h3><div>A retrospective, observational, cohort analysis was performed on data extrapolated from our institution’s intracranial hemorrhage (ICH) screening log. All patients included in this study either (1) were excluded from the ENRICH trial for not meeting trial inclusion criteria or (2) presented on and after February 27<sup>th</sup>, 2019 when BGHs. This inflection point in time was chosen based on the ENRICH trial’s decision to enact an a priori futility rule. Demographical, medical comorbities, presenting features, treatment characteristics, and outcomes were collected by chart review on all patients. These dichotimized groups were compared by univariate and multivariate statistical approaches. The main outcome of interest was functional status at 90 days as measured by the modified Rankin Scale.</div></div><div><h3>Results</h3><div>There were 52 patients with BGHs who presented before the interim exclusion decision, and 67 patients who presented after. The proportion of patients with intraventricular hemorrhage (IVH) occupying > 50 % of either lateral ventricle was higher in the “before” group (40.4 % vs 20.9 %, p = 0.026). There was a significant difference in the evacuation method used, with more patients in the “after” group undergoing craniotomy (10.5 % vs 0 %, p = 0.018). The 90-day mRS scores of 0–2 were significantly lower for patients who presented after the interim exclusion (16.4 % vs 36.5 %, p = 0.019). The 180-day mortality was not significantly different between the two groups (p = 0.56). In multivariate logistical regression, diabetes mellitus, hematoma volume at presentation, and presentation date were significant predictors of a “good” neurological outcome (90-day mRS score of 0–2). A 1 mL increase in hematoma volume at presentation was associated with a 4 % decrease in the likelihood of a good outcome (OR = 0.960, 95 % CI = 0.924–0.997, p = 0.033). Patients who presented after the interim exclusion had a 79.5 % lower likelihood of a “good” neurological outcome compared to those who presented before the interim exclusion (OR = 0.20
目的早期微创清除脑内出血(ENRICH)试验旨在评估微创经胼胝体筋膜旁手术(MIPS)方法,该技术经宣传可安全进入大脑深部结构,并使用 BrainPath® 和 Myriad® 设备(NICO 公司,印第安纳州印第安纳波利斯)清除 ICH。然而,基底节出血(BGH)被确定为符合先验无用性规则,因此被排除在进一步的试验注册考虑之外。由于ICH筛查是在有症状的患者出现后立即开始的,因此治疗的缩减是为了最好地保护剩余的神经功能。我们试图确定,尽管进行了最佳的内科或外科治疗,但立即被排除在试验考虑范围之外是否会导致患者预后较差。方法:我们对本机构颅内出血(ICH)筛查日志中的数据进行了回顾性、观察性、队列分析。纳入本研究的所有患者要么(1)因不符合ENRICH试验纳入标准而被排除在外,要么(2)在2019年2月27日及之后出现BGH。这个时间拐点是根据 ENRICH 试验制定先验无效规则的决定选定的。通过病历审查收集了所有患者的人口统计学特征、合并症、发病特征、治疗特征和结果。通过单变量和多变量统计方法对这些二分法分组进行了比较。主要研究结果是90天后的功能状态,用改良Rankin量表来衡量。结果在临时排除决定之前,有52例BGH患者,在临时排除决定之后,有67例患者。脑室内出血(IVH)占任一侧脑室50%的患者比例在 "前 "组中更高(40.4% vs 20.9%,P = 0.026)。在采用的排空方法上有明显差异,"术后 "组中接受开颅手术的患者更多(10.5% 对 0%,P = 0.018)。临时排除后就诊的患者 90 天 mRS 评分为 0-2 分的比例明显较低(16.4% 对 36.5%,p = 0.019)。两组患者的 180 天死亡率无明显差异(p = 0.56)。在多变量逻辑回归中,糖尿病、发病时的血肿量和发病日期是预测神经系统预后 "良好"(90 天 mRS 评分为 0-2)的重要因素。发病时血肿体积每增加 1 毫升,预后良好的可能性就会降低 4%(OR = 0.960,95 % CI = 0.924-0.997,p = 0.033)。与临时排除前的患者相比,临时排除后就诊的患者获得 "良好 "神经功能预后的可能性降低了 79.5%(OR = 0.205,95 % CI = 0.063-0.669,p = 0.009)。
{"title":"Recent trends of treatment strategies and outcomes of basal ganglia hemorrhages at a single institution","authors":"","doi":"10.1016/j.hest.2024.03.001","DOIUrl":"10.1016/j.hest.2024.03.001","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;The Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH) Trial was designed to evaluate the minimally invasive &lt;em&gt;trans&lt;/em&gt;-sulcal parafascicular surgery (MIPS) approach, a technique advertised for safe access to deep brain structures and ICH removal using the BrainPath® and Myriad® devices (NICO Corporation, Indianapolis, IN). However, basal ganglia hemorrhages (BGHs) were determined to meet the a priori futility rule, resulting in exclusion from further trial enrollment consideration. Since screening for ICH is initiated immediately upon presentation of symptom bearing patients, treatment is curtailed to best preserve remaining neurological function. We sought to determine whether immediate exclusion from consideration of trial enrollment resulted in poorer patient outcomes despite best medical or surgical management.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;A retrospective, observational, cohort analysis was performed on data extrapolated from our institution’s intracranial hemorrhage (ICH) screening log. All patients included in this study either (1) were excluded from the ENRICH trial for not meeting trial inclusion criteria or (2) presented on and after February 27&lt;sup&gt;th&lt;/sup&gt;, 2019 when BGHs. This inflection point in time was chosen based on the ENRICH trial’s decision to enact an a priori futility rule. Demographical, medical comorbities, presenting features, treatment characteristics, and outcomes were collected by chart review on all patients. These dichotimized groups were compared by univariate and multivariate statistical approaches. The main outcome of interest was functional status at 90 days as measured by the modified Rankin Scale.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;There were 52 patients with BGHs who presented before the interim exclusion decision, and 67 patients who presented after. The proportion of patients with intraventricular hemorrhage (IVH) occupying &gt; 50 % of either lateral ventricle was higher in the “before” group (40.4 % vs 20.9 %, p = 0.026). There was a significant difference in the evacuation method used, with more patients in the “after” group undergoing craniotomy (10.5 % vs 0 %, p = 0.018). The 90-day mRS scores of 0–2 were significantly lower for patients who presented after the interim exclusion (16.4 % vs 36.5 %, p = 0.019). The 180-day mortality was not significantly different between the two groups (p = 0.56). In multivariate logistical regression, diabetes mellitus, hematoma volume at presentation, and presentation date were significant predictors of a “good” neurological outcome (90-day mRS score of 0–2). A 1 mL increase in hematoma volume at presentation was associated with a 4 % decrease in the likelihood of a good outcome (OR = 0.960, 95 % CI = 0.924–0.997, p = 0.033). Patients who presented after the interim exclusion had a 79.5 % lower likelihood of a “good” neurological outcome compared to those who presented before the interim exclusion (OR = 0.20","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 5","pages":"Pages 205-212"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140276018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous arterial blood pressure indices and early hematoma expansion in patients with spontaneous intracerebral hemorrhage 自发性脑出血患者的连续动脉血压指数与早期血肿扩大
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.hest.2024.06.001

Objective

Blood pressure variability (BPV) and its potential association with early hematoma expansion (HE) in intracerebral hemorrhage (ICH) remains to be fully elucidated. Our study explores the potential link between BPV within the first 24 h after admission and HE in ICH.

Methods

In a prospective cohort single-center study, we analyzed consecutive patients with spontaneous ICH. Continuous BP data via an arterial line extracted from the Intellispace Critical Care and Anesthesia information system (Philips Healthcare) were analyzed over 0–2, 0–8, 0–12, and 0–24 h intervals post-admission. BPV was assessed through successive variability (SV), standard deviation (SD), and coefficient of variation (CV) using all available BP measurements. Early HE was defined as an absolute [≥ 6 ml] or relative [≥ 33 %] increase in ICH volume on 24-hours follow-up brain imaging. Secondary endpoints were the influence of BP on admission and other potential risk factors for HE.

Results

Among 305 ICH-patients (mean age ± SD 70.1 ± 14.9 years, 47.9 % female, median NIHSS 6 (3, 13), median ICH score 1 (1, 2)), 41 (13.4 %) experienced HE. HE-patients had higher NIHSS (p = 0.015), ICH-score (p = 0.005), ICH volume (p < 0.001) and higher pre-anticoagulation treatment (p = 0.004) on admission. There was no difference in BPV comparing ICH-patients with HE to those without. However, patients with HE had significantly lower diastolic BP (76.6 ± 14.8 vs. 86.3 ± 19.7 mmHg, p = 0.005) and MAP (103.2 ± 22.4 vs. 112.2 ± 22.6, p = 0.027) on admission. This pattern of lower diastolic BP persisted across the first 24 h. Logistic regression revealed larger ICH volume and pre-existing anticoagulation as significant predictors of HE, with higher initial diastolic BP reducing HE risk. Hemorrhages ≥ 30 cm3 showed significantly lower initial diastolic BP, MAP, and BPV across all time frames compared to ICH < 30 cm3.

Conclusions

BPV within the first 24 h was not associated with HE. Lower diastolic BP on admission, anticoagulation use, and larger ICH volume are potential predictors for HE. However, larger hemorrhage size (>30 cm3) experienced lower absolute BP and BPV indices and worse clinical outcomes. These findings suggest a nuanced relationship between BP dynamics and ICH severity, underscoring the need for individualized BP management in acute ICH care. Further research is necessary to explore these relationships and optimize treatment strategies.
目的血压变异性(BPV)及其与脑内出血(ICH)早期血肿扩大(HE)的潜在联系仍有待全面阐明。我们的研究探讨了入院后 24 小时内的血压变异与 ICH 中血肿扩大之间的潜在联系。方法在一项前瞻性队列单中心研究中,我们分析了连续的自发性 ICH 患者。我们分析了入院后 0-2、0-8、0-12 和 0-24 小时内通过动脉管路提取的连续血压数据。通过所有可用血压测量值的连续变异性 (SV)、标准差 (SD) 和变异系数 (CV) 评估血压变异性。早期 HE 的定义是 24 小时随访脑成像中 ICH 体积绝对值[≥ 6 ml]或相对值[≥ 33 %]增加。次要终点是入院时血压的影响以及 HE 的其他潜在风险因素。结果在 305 名 ICH 患者(平均年龄(± SD)70.1±14.9 岁,47.9% 为女性,中位 NIHSS 6(3,13)分,中位 ICH 评分 1(1,2)分)中,41 人(13.4%)出现 HE。HE 患者入院时的 NIHSS(p = 0.015)、ICH 评分(p = 0.005)、ICH 容量(p < 0.001)和抗凝前治疗(p = 0.004)均较高。有高血压的 ICH 患者与没有高血压的患者相比,BPV 没有差异。但 HE 患者入院时的舒张压(76.6 ± 14.8 vs. 86.3 ± 19.7 mmHg,p = 0.005)和血压(103.2 ± 22.4 vs. 112.2 ± 22.6,p = 0.027)明显较低。逻辑回归显示,较大的 ICH 容量和预先存在的抗凝是 HE 的重要预测因素,而较高的初始舒张压可降低 HE 风险。与 ICH < 30 cm3 相比,出血量≥ 30 cm3 的患者在所有时间段内的初始舒张压、MAP 和 BPV 都明显较低。入院时舒张压较低、使用抗凝药和较大的 ICH 容量是 HE 的潜在预测因素。然而,出血量较大(30 立方厘米)的患者绝对血压和血压变异指数较低,临床预后较差。这些研究结果表明,血压动态变化与 ICH 严重程度之间存在微妙的关系,强调了在急性 ICH 护理中进行个体化血压管理的必要性。有必要开展进一步的研究来探索这些关系并优化治疗策略。
{"title":"Continuous arterial blood pressure indices and early hematoma expansion in patients with spontaneous intracerebral hemorrhage","authors":"","doi":"10.1016/j.hest.2024.06.001","DOIUrl":"10.1016/j.hest.2024.06.001","url":null,"abstract":"<div><h3>Objective</h3><div>Blood pressure variability (BPV) and its potential association with early hematoma expansion (HE) in intracerebral hemorrhage (ICH) remains to be fully elucidated. Our study explores the potential link between BPV within the first 24 h after admission and HE in ICH.</div></div><div><h3>Methods</h3><div>In a prospective cohort single-center study, we analyzed consecutive patients with spontaneous ICH. Continuous BP data via an arterial line extracted from the Intellispace Critical Care and Anesthesia information system (Philips Healthcare) were analyzed over 0–2, 0–8, 0–12, and 0–24 h intervals post-admission. BPV was assessed through successive variability (SV), standard deviation (SD), and coefficient of variation (CV) using all available BP measurements. Early HE was defined as an absolute [≥ 6 ml] or relative [≥ 33 %] increase in ICH volume on 24-hours follow-up brain imaging. Secondary endpoints were the influence of BP on admission and other potential risk factors for HE.</div></div><div><h3>Results</h3><div>Among 305 ICH-patients (mean age ± SD 70.1 ± 14.9 years, 47.9 % female, median NIHSS 6 (3, 13), median ICH score 1 (1, 2)), 41 (13.4 %) experienced HE. HE-patients had higher NIHSS (p = 0.015), ICH-score (p = 0.005), ICH volume (p &lt; 0.001) and higher pre-anticoagulation treatment (p = 0.004) on admission. There was no difference in BPV comparing ICH-patients with HE to those without. However, patients with HE had significantly lower diastolic BP (76.6 ± 14.8 vs. 86.3 ± 19.7 mmHg, p = 0.005) and MAP (103.2 ± 22.4 vs. 112.2 ± 22.6, p = 0.027) on admission. This pattern of lower diastolic BP persisted across the first 24 h. Logistic regression revealed larger ICH volume and pre-existing anticoagulation as significant predictors of HE, with higher initial diastolic BP reducing HE risk. Hemorrhages ≥ 30 cm<sup>3</sup> showed significantly lower initial diastolic BP, MAP, and BPV across all time frames compared to ICH &lt; 30 cm<sup>3</sup>.</div></div><div><h3>Conclusions</h3><div>BPV within the first 24 h was not associated with HE. Lower diastolic BP on admission, anticoagulation use, and larger ICH volume are potential predictors for HE. However, larger hemorrhage size (&gt;30 cm<sup>3</sup>) experienced lower absolute BP and BPV indices and worse clinical outcomes. These findings suggest a nuanced relationship between BP dynamics and ICH severity, underscoring the need for individualized BP management in acute ICH care. Further research is necessary to explore these relationships and optimize treatment strategies.</div></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 5","pages":"Pages 213-222"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141393174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum cholesterol and interleukin-10 are associated with post-intracerebral hemorrhage depression in patients with acute primary supratentorial intracerebral hemorrhage 血清胆固醇和白细胞介素-10 与急性原发性颅内上出血患者脑出血后抑郁有关
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.hest.2024.05.006
Liping Wei , Zhihua Liu , Huimin Cai , Huihong Tian , Jie Tan , Yuhu Zhang , Lijuan Wang , Yuyuan Gao , Jian Wang , Limin Wang

Objectives

This study explores the correlation between serum cholesterol, interleukin-10 (IL-10), macrophage migration inhibitory factor (MIF), and post-intracerebral hemorrhage (post-ICH) depression in patients with acute ICH.

Methods

35 patients with acute primary supratentorial ICH were recruited. Serum cholesterol, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDLC), and low-density lipoprotein cholesterol (LDLC), IL-10, and MIF were measured in the first morning after admission. Additionally, a 24-item Hamilton Depression Scale (HAMD-24) was used to detect depressive symptoms one week after admission. HAMD scores ≥ 8 indicated a diagnosis of post-ICH depression.

Results

The levels of TC were significantly lower in ICH patients with depression compared to those without [169.26(139.23–215.67) mg/dL vs. 200.46(182.81–224.74) mg/dL, P = 0.010]. Similarly, levels of LDLC [102.18(78.39–137.28) mg/dL vs. 135.14(120.22–170.63) mg/dL, P = 0.001] and IL-10 [17.56(16.03–22.52) pg/mL vs. 31.17(23.42–37.53) pg/mL, P = 0.001] were also lower in patients with post-ICH depression. Furthermore, the levels of TC (r = -0.433, P = 0.009), TG (r = -0.345, P = 0.043), LDLC (r = -0.549, P = 0.001), and IL-10 levels (r = -0.603, P < 0.001) showed negative correlations with the HAMD scores. Logistic regression analysis indicated that higher IL-10 levels (OR = 0.847, 95 % CI = 0.717–0.999, P = 0.049) were indicative of protection against post-ICH depression in the acute phase.

Conclusion

Lower levels of TC, LDLC, and IL-10 were associated with post-ICH depression during the acute phase. Furthermore, decreased levels of IL-10 may serve as a promising predictor for post-ICH depression.
目的 本研究探讨了急性ICH患者血清胆固醇、白细胞介素-10(IL-10)、巨噬细胞迁移抑制因子(MIF)与脑出血后(ICH)抑郁之间的相关性。入院后第一天早晨测量血清胆固醇,包括总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDLC)和低密度脂蛋白胆固醇(LDLC)、IL-10和MIF。此外,入院一周后,使用 24 项汉密尔顿抑郁量表(HAMD-24)检测抑郁症状。结果 患有抑郁症的 ICH 患者 TC 水平明显低于未患抑郁症的患者 [169.26(139.23-215.67) mg/dL vs. 200.46(182.81-224.74) mg/dL, P = 0.010]。同样,ICH 后抑郁症患者的 LDLC [102.18(78.39-137.28) mg/dL vs. 135.14(120.22-170.63) mg/dL, P = 0.001]和 IL-10 [17.56(16.03-22.52) pg/mL vs. 31.17(23.42-37.53) pg/mL, P = 0.001]水平也较低。此外,TC(r = -0.433,P = 0.009)、TG(r = -0.345,P = 0.043)、LDLC(r = -0.549,P = 0.001)和 IL-10 水平(r = -0.603,P <0.001)与 HAMD 评分呈负相关。逻辑回归分析表明,较高的IL-10水平(OR = 0.847,95 % CI = 0.717-0.999,P = 0.049)表明在急性期可预防ICH后抑郁。此外,IL-10水平的降低可作为ICH后抑郁的预测因子。
{"title":"Serum cholesterol and interleukin-10 are associated with post-intracerebral hemorrhage depression in patients with acute primary supratentorial intracerebral hemorrhage","authors":"Liping Wei ,&nbsp;Zhihua Liu ,&nbsp;Huimin Cai ,&nbsp;Huihong Tian ,&nbsp;Jie Tan ,&nbsp;Yuhu Zhang ,&nbsp;Lijuan Wang ,&nbsp;Yuyuan Gao ,&nbsp;Jian Wang ,&nbsp;Limin Wang","doi":"10.1016/j.hest.2024.05.006","DOIUrl":"10.1016/j.hest.2024.05.006","url":null,"abstract":"<div><h3>Objectives</h3><div>This study explores the correlation between serum cholesterol, interleukin-10 (IL-10), macrophage migration inhibitory factor (MIF), and post-intracerebral hemorrhage (post-ICH) depression in patients with acute ICH.</div></div><div><h3>Methods</h3><div>35 patients with acute primary supratentorial ICH were recruited. Serum cholesterol, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDLC), and low-density lipoprotein cholesterol (LDLC), IL-10, and MIF were measured in the first morning after admission. Additionally, a 24-item Hamilton Depression Scale (HAMD-24) was used to detect depressive symptoms one week after admission. HAMD scores ≥ 8 indicated a diagnosis of post-ICH depression.</div></div><div><h3>Results</h3><div>The levels of TC were significantly lower in ICH patients with depression compared to those without [169.26(139.23–215.67) mg/dL vs. 200.46(182.81–224.74) mg/dL, <em>P</em> = 0.010]. Similarly, levels of LDLC [102.18(78.39–137.28) mg/dL vs. 135.14(120.22–170.63) mg/dL, <em>P</em> = 0.001] and IL-10 [17.56(16.03–22.52) pg/mL vs. 31.17(23.42–37.53) pg/mL, <em>P</em> = 0.001] were also lower in patients with post-ICH depression. Furthermore, the levels of TC (r = -0.433, <em>P</em> = 0.009), TG (r = -0.345, <em>P</em> = 0.043), LDLC (r = -0.549, <em>P</em> = 0.001), and IL-10 levels (r = -0.603, <em>P</em> &lt; 0.001) showed negative correlations with the HAMD scores. Logistic regression analysis indicated that higher IL-10 levels (OR = 0.847, 95 % CI = 0.717–0.999, <em>P</em> = 0.049) were indicative of protection against post-ICH depression in the acute phase.</div></div><div><h3>Conclusion</h3><div>Lower levels of TC, LDLC, and IL-10 were associated with post-ICH depression during the acute phase. Furthermore, decreased levels of IL-10 may serve as a promising predictor for post-ICH depression.</div></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 5","pages":"Pages 237-242"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of mesenchymal stem cell-derived exosomes on the inflammatory response after stroke 间充质干细胞衍生的外泌体对中风后炎症反应的影响
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.hest.2024.04.003
Stroke, characterized by sudden onset and significant mortality rates, represents a critical challenge in effectively treating neuroinflammation to improve treatment efficacy. In this context, mesenchymal stem cell (MSC)-derived exosomes have attracted significant attention in scientific research due to their diverse cellular origin, tiny size, and huge number of bioactive molecules. Recent studies have shed light on the remarkable potential of MSC-derived exosomes to not only suppress the inflammatory responses of microglia and astrocytes, but also enhance their neuroprotective functions. Moreover, these exosomes have demonstrated a remarkable ability to modulate various immune cells and inflammatory mediators, thereby exerting profound mitigating effects on neuroinflammation. Through a thorough examination of the role and underlying mechanisms of MSC-derived exosomes in mitigating neuroinflammation after stroke, this review aims to provide comprehensive information and recommendations for the development of innovative therapeutic strategies aimed at significantly improving the treatment of stroke.
脑卒中具有发病突然、死亡率高的特点,是有效治疗神经炎症以提高疗效的重大挑战。在这种情况下,间充质干细胞(MSC)衍生的外泌体因其细胞来源多样、体积微小、含有大量生物活性分子而在科学研究中备受关注。最近的研究表明,间充质干细胞衍生的外泌体不仅具有抑制小胶质细胞和星形胶质细胞炎症反应的显著潜力,还能增强它们的神经保护功能。此外,这些外泌体还显示出调节各种免疫细胞和炎症介质的卓越能力,从而对神经炎症产生深远的缓解作用。本综述旨在通过深入研究间充质干细胞衍生的外泌体在缓解脑卒中后神经炎症中的作用及其内在机制,为开发创新治疗策略提供全面的信息和建议,从而显著改善脑卒中的治疗。
{"title":"Effect of mesenchymal stem cell-derived exosomes on the inflammatory response after stroke","authors":"","doi":"10.1016/j.hest.2024.04.003","DOIUrl":"10.1016/j.hest.2024.04.003","url":null,"abstract":"<div><div>Stroke, characterized by sudden onset and significant mortality rates, represents a critical challenge in effectively treating neuroinflammation to improve treatment efficacy. In this context, mesenchymal stem cell (MSC)-derived exosomes have attracted significant attention in scientific research due to their diverse cellular origin, tiny size, and huge number of bioactive molecules. Recent studies have shed light on the remarkable potential of MSC-derived exosomes to not only suppress the inflammatory responses of microglia and astrocytes, but also enhance their neuroprotective functions. Moreover, these exosomes have demonstrated a remarkable ability to modulate various immune cells and inflammatory mediators, thereby exerting profound mitigating effects on neuroinflammation. Through a thorough examination of the role and underlying mechanisms of MSC-derived exosomes in mitigating neuroinflammation after stroke, this review aims to provide comprehensive information and recommendations for the development of innovative therapeutic strategies aimed at significantly improving the treatment of stroke.</div></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 5","pages":"Pages 248-256"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140774396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemorrhage of the hypothalamic cavernous malformation. Clinical case of surgical treatment 下丘脑海绵状畸形出血。手术治疗的临床病例
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.hest.2024.04.005

Objective

To study the clinical and neurologic symptoms and to determine the indications for surgical treatment of hypothalamic cavernous malformations.

Methods

We reviewed scientific literature devoted to hypothalamic cavernomas and compared the clinical symptomatology with our clinical case.

Results

The article describes the clinical manifestations of the presented case. A comparative analysis of previously described cases was carried out, and the retionale was presented on the possibility of clinical manifestations depending on the direction of extra-focal hemorrhage. Diagnostic and differential diagnostic aspects of cavernomas of this localization are also described. A case of successful surgical treatment of cavernous malformation of the hypothalamus is presented, and it is also shared with the motives of supporters of conservative treatment by other authors.

Conclusion

This case and literature review illustrate the variability of neurological symptoms of hypothalamic cavernous malformation haemorrhage and describe indications for surgical treatment.
目的研究下丘脑海绵状瘤的临床和神经系统症状,并确定手术治疗的适应症。方法我们查阅了有关下丘脑海绵状瘤的科学文献,并将临床症状与我们的临床病例进行了比较。文章对以前描述过的病例进行了比较分析,并就病灶外出血方向可能导致的临床表现提出了理论依据。此外,还介绍了这种定位的海绵体瘤的诊断和鉴别诊断方面的问题。结论本病例和文献综述说明了下丘脑海绵状畸形出血神经症状的可变性,并描述了手术治疗的适应症。
{"title":"Hemorrhage of the hypothalamic cavernous malformation. Clinical case of surgical treatment","authors":"","doi":"10.1016/j.hest.2024.04.005","DOIUrl":"10.1016/j.hest.2024.04.005","url":null,"abstract":"<div><h3>Objective</h3><div>To study the clinical and neurologic symptoms and to determine the indications for surgical treatment of hypothalamic cavernous malformations.</div></div><div><h3>Methods</h3><div>We reviewed scientific literature devoted to hypothalamic cavernomas and compared the clinical symptomatology with our clinical case.</div></div><div><h3>Results</h3><div>The article describes the clinical manifestations of the presented case. A comparative analysis of previously described cases was carried out, and the retionale was presented on the possibility of clinical manifestations depending on the direction of extra-focal hemorrhage. Diagnostic and differential diagnostic aspects of cavernomas of this localization are also described. A case of successful surgical treatment of cavernous malformation of the hypothalamus is presented, and it is also shared with the motives of supporters of conservative treatment by other authors.</div></div><div><h3>Conclusion</h3><div>This case and literature review illustrate the variability of neurological symptoms of hypothalamic cavernous malformation haemorrhage and describe indications for surgical treatment.</div></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 5","pages":"Pages 257-260"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140764831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain hemorrhages in traumatic brain injury and the excess burden conferred by anticoagulants and antiplatelets 脑外伤中的脑出血以及抗凝剂和抗血小板药物带来的额外负担
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.hest.2024.05.003

Objective

The objective of this study was to compare the severity of head injury in patients on an anticoagulant or antiplatelet agent and to look at the burden of these medications in patients 55 + years vs. younger.

Methods

This was an observational cohort study of 2256 adult head trauma patients who presented to a Level I Trauma Center and were stratified by anticoagulant/antiplatelet medication use and age. Logistic regression analyses were performed to ascertain whether use of these medications resulted in worse outcomes.

Results

Overall, elderly (>55yrs) patients had worse outcomes after TBI. Specifically, they were more likely to have an intracranial hemorrhage, be admitted to the hospital, have an ICU stay, be re-admitted within 30 days, die in the hospital and be dead within 3 months.

Conclusion

Geriatric trauma patients along with their preexisting comorbidities are often on anticoagulants that increase their risk for complications, bleeding, mortality in the setting of even minor traumas.
方法这是一项观察性队列研究,研究对象是2256名前往一级创伤中心就诊的成人头部创伤患者,根据抗凝剂/抗血小板药物的使用情况和年龄对患者进行分层。结果总体而言,老年(55 岁)患者的创伤后预后较差。具体而言,他们更有可能出现颅内出血、入院、住重症监护室、30 天内再次入院、在医院死亡以及在 3 个月内死亡。结论老年创伤患者及其原有的合并症往往需要服用抗凝药物,这增加了他们出现并发症、出血和轻微创伤时死亡的风险。
{"title":"Brain hemorrhages in traumatic brain injury and the excess burden conferred by anticoagulants and antiplatelets","authors":"","doi":"10.1016/j.hest.2024.05.003","DOIUrl":"10.1016/j.hest.2024.05.003","url":null,"abstract":"<div><h3>Objective</h3><div>The objective of this study was to compare the severity of head injury in patients on an anticoagulant or antiplatelet agent and to look at the burden of these medications in patients 55 + years vs. younger.</div></div><div><h3>Methods</h3><div>This was an observational cohort study of 2256 adult head trauma patients who presented to a Level I Trauma Center and were stratified by anticoagulant/antiplatelet medication use and age. Logistic regression analyses were performed to ascertain whether use of these medications resulted in worse outcomes.</div></div><div><h3>Results</h3><div>Overall, elderly (&gt;55yrs) patients had worse outcomes after TBI. Specifically, they were more likely to have an intracranial hemorrhage, be admitted to the hospital, have an ICU stay, be re-admitted within 30 days, die in the hospital and be dead within 3 months.</div></div><div><h3>Conclusion</h3><div>Geriatric trauma patients along with their preexisting comorbidities are often on anticoagulants that increase their risk for complications, bleeding, mortality in the setting of even minor traumas.</div></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 5","pages":"Pages 233-236"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141136479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VASP, HCLS1, MSN, and EZR: Key molecular beacons in the pathophysiology of perihematomal edema Post-Intracerebral hemorrhage VASP、HCLS1、MSN 和 EZR:脑出血后血肿周围水肿病理生理学中的关键分子信标
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.hest.2024.04.002

Objective

Perihematomal edema (PHE) is one of the significant secondary cerebral damages, with the blood–brain barrier's integrity playing a pivotal role in its progression. Strengthening tight junction (TJ) proteins enhances blood–brain barrier integrity, yet the complex genetics behind brain edema remain not fully understood. Our research endeavors to uncover pivotal genes and their roles in brain edema following cerebral hemorrhage, and to investigate potential treatment strategies.

Methods

By analyzing intracerebral hemorrhage (ICH) and control samples using the GSE216607 and GSE206971 datasets, we identified differentially expressed genes. Cross-referencing with the KEGG database, we aligned these genes with those related to tight junctions. Extensive enrichment analysis and protein interactions were performed to examine the expression and clinical significance of the identified genes. Our study employed the C57BL/6J mouse ICH model and qRT-PCR for key gene validation.

Results

Notably, VASP, HCLS1, MSN, and EZR, critical for tight junctions, showed increased expression post-ICH, emphasizing their significance in BBB upkeep and PHE progression. Drug validation indicated potential therapeutic effects of Testosterone enanthate, SELENIUM, and LY 294002 on tight junction-related genes.

Conclusion

This study sheds light on the potential involvement of these genes in brain edema progression post-ICH, offering promising therapeutic targets. Further research is needed for deeper understanding.
目的血脑屏障水肿(PHE)是严重的继发性脑损伤之一,血脑屏障的完整性在其发展过程中起着关键作用。加强紧密连接(TJ)蛋白可提高血脑屏障的完整性,但脑水肿背后复杂的遗传学机制仍未完全明了。我们的研究致力于发现脑出血后脑水肿的关键基因及其在脑水肿中的作用,并研究潜在的治疗策略。方法通过使用 GSE216607 和 GSE206971 数据集分析脑出血(ICH)和对照样本,我们确定了差异表达的基因。通过与 KEGG 数据库交叉比对,我们将这些基因与紧密连接相关基因进行了比对。我们还进行了广泛的富集分析和蛋白质相互作用分析,以检验所发现基因的表达和临床意义。我们的研究采用了 C57BL/6J 小鼠 ICH 模型和 qRT-PCR 方法对关键基因进行验证。药物验证表明,庚酸睾酮、SELENIUM和LY 294002对紧密连接相关基因具有潜在的治疗作用。需要进一步研究以加深理解。
{"title":"VASP, HCLS1, MSN, and EZR: Key molecular beacons in the pathophysiology of perihematomal edema Post-Intracerebral hemorrhage","authors":"","doi":"10.1016/j.hest.2024.04.002","DOIUrl":"10.1016/j.hest.2024.04.002","url":null,"abstract":"<div><h3>Objective</h3><div>Perihematomal edema (PHE) is one of the significant secondary cerebral damages, with the blood–brain barrier's integrity playing a pivotal role in its progression. Strengthening tight junction (TJ) proteins enhances blood–brain barrier integrity, yet the complex genetics behind brain edema remain not fully understood. Our research endeavors to uncover pivotal genes and their roles in brain edema following cerebral hemorrhage, and to investigate potential treatment strategies.</div></div><div><h3>Methods</h3><div>By analyzing intracerebral hemorrhage (ICH) and control samples using the GSE216607 and GSE206971 datasets, we identified differentially expressed genes. Cross-referencing with the KEGG database, we aligned these genes with those related to tight junctions. Extensive enrichment analysis and protein interactions were performed to examine the expression and clinical significance of the identified genes. Our study employed the C57BL/6J mouse ICH model and qRT-PCR for key gene validation.</div></div><div><h3>Results</h3><div>Notably, VASP, HCLS1, MSN, and EZR, critical for tight junctions, showed increased expression post-ICH, emphasizing their significance in BBB upkeep and PHE progression. Drug validation indicated potential therapeutic effects of Testosterone enanthate, SELENIUM, and LY 294002 on tight junction-related genes.</div></div><div><h3>Conclusion</h3><div>This study sheds light on the potential involvement of these genes in brain edema progression post-ICH, offering promising therapeutic targets. Further research is needed for deeper understanding.</div></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 5","pages":"Pages 223-232"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140789592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic yield of different imaging modalities in the detection rate of intracranial aneurysm remnants after microsurgical clipping – A systematic review and meta-analysis 不同成像模式对显微手术切除后颅内动脉瘤残余物检出率的诊断率--系统回顾和荟萃分析
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.hest.2024.07.002
Raphael Sidler , Lukas Andereggen , Gerrit A. Schubert , Basil E. Grüter , Serge Marbacher

Objective

While the long-term durability of completely clipped intracranial aneurysms (IA) is excellent, IA with remnants poses a significant risk for future re-growth with subsequent need for long-term follow-up or requirement for retreatment. We aim at reviewing the detection rate of IA remnants after clip ligation in the imaging modalities used to date.

Methods

A systematic review was performed according to the PRISMA guidelines using the PubMed/Medline database. The search terms included “intracranial aneurysm” AND “remnant” either in combination with “digital subtraction angiography” OR “computed tomography angiography” OR “indocyanine green video angiography”.

Results

The overall observed prevalence of IA remnants after clipping was 5.9 %, 10.9 %, 12.5 %, 14.1 % and 28.3 %, using ICG-VA, intraoperative 2D-DSA, CTA, and 3D-DSA, respectively. In studies comparing all imaging modalities altogether, 3D-DSA performed significantly better (p < 0.001) than any other single modality. The diagnostic yield of CTA and DSA gradually improved over time. Irrespective of imaging modality the percentage of IA remnants is higher in ruptured than unruptured IAs.

Conclusion

Although the diagnostic yield of CTA and 2D-DSA have substantially improved over recent years 3D-DSA provides the highest overall detection rate of clipped IA remnants. In direct comparison, 3D-DSA performs better than any other imaging modality.
目的虽然完全夹闭的颅内动脉瘤(IA)的长期耐久性非常好,但有残余物的IA在未来再次生长的风险很大,因此需要长期随访或进行再治疗。我们的目的是回顾迄今为止所使用的成像模式中夹子结扎后颅内动脉瘤残余的检出率。方法根据PRISMA指南,使用PubMed/Medline数据库进行了系统性回顾。检索词包括 "颅内动脉瘤 "和 "残余",可与 "数字减影血管造影 "或 "计算机断层扫描血管造影 "或 "吲哚青绿视频血管造影 "结合使用。在对所有成像模式进行综合比较的研究中,3D-DSA 的表现明显优于任何其他单一模式(p < 0.001)。随着时间的推移,CTA 和 DSA 的诊断率逐渐提高。结论虽然近年来 CTA 和 2D-DSA 的诊断率有了大幅提高,但 3D-DSA 对剪除的 IA 残留物的总体检出率最高。直接比较而言,3D-DSA 的表现优于任何其他成像模式。
{"title":"Diagnostic yield of different imaging modalities in the detection rate of intracranial aneurysm remnants after microsurgical clipping – A systematic review and meta-analysis","authors":"Raphael Sidler ,&nbsp;Lukas Andereggen ,&nbsp;Gerrit A. Schubert ,&nbsp;Basil E. Grüter ,&nbsp;Serge Marbacher","doi":"10.1016/j.hest.2024.07.002","DOIUrl":"10.1016/j.hest.2024.07.002","url":null,"abstract":"<div><h3>Objective</h3><div>While the long-term durability of completely clipped intracranial aneurysms (IA) is excellent, IA with remnants poses a significant risk for future re-growth with subsequent need for long-term follow-up or requirement for retreatment. We aim at reviewing the detection rate of IA remnants after clip ligation in the imaging modalities used to date.</div></div><div><h3>Methods</h3><div>A systematic review was performed according to the PRISMA guidelines using the PubMed/Medline database. The search terms included “intracranial aneurysm” AND “remnant” either in combination with “digital subtraction angiography” OR “computed tomography angiography” OR “indocyanine green video angiography”.</div></div><div><h3>Results</h3><div>The overall observed prevalence of IA remnants after clipping was 5.9 %, 10.9 %, 12.5 %, 14.1 % and 28.3 %, using ICG-VA, intraoperative 2D-DSA, CTA, and 3D-DSA, respectively. In studies comparing all imaging modalities altogether, 3D-DSA performed significantly better (p &lt; 0.001) than any other single modality. The diagnostic yield of CTA and DSA gradually improved over time. Irrespective of imaging modality the percentage of IA remnants is higher in ruptured than unruptured IAs.</div></div><div><h3>Conclusion</h3><div>Although the diagnostic yield of CTA and 2D-DSA have substantially improved over recent years 3D-DSA provides the highest overall detection rate of clipped IA remnants. In direct comparison, 3D-DSA performs better than any other imaging modality.</div></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 5","pages":"Pages 243-247"},"PeriodicalIF":1.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141694397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased plasma pigment epithelium-derived factor (PEDF) concentrations as a negative predictor of angiographic vasospasm after aneurysmal subarachnoid hemorrhage 血浆色素上皮衍生因子(PEDF)浓度的增加是动脉瘤性蛛网膜下腔出血后血管造影血管痉挛的负面预测因子
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.hest.2024.02.001

Objective

Cerebral vasospasm remains a major determinant of delayed cerebral ischemia (DCI) and poor outcomes after aneurysmal subarachnoid hemorrhage (SAH). This study was aimed to investigate if a matricellular protein pigment epithelium-derived factor (PEDF) can be a biomarker of angiographic vasospasm (aVSP) after SAH.

Methods

In 197 consecutive patients with aneurysmal SAH, plasma PEDF concentrations were serially measured at days 1–12 post-SAH.

Results

Plasma PEDF concentrations in SAH patients were elevated compared with patients with unruptured cerebral aneurysms, and especially higher in patients with admission World Federation of Neurological Surgeons (WFNS) grades IV–V. However, higher plasma PEDF concentrations at days 1–3 and 10–12 were associated with no development of aVSP. In an analysis limited to 72 non-sedated patients with preoperative WFNS grades I–III, plasma PEDF concentrations were also significantly higher in patients with neither DCI nor aVSP. Multivariate analysis showed that increased plasma PEDF concentration at days 1–3 was an independent predictor of no development of aVSP.

Conclusion

This was the first study to measure plasma PEDF concentrations and to show the relationships with aVSP development in SAH patients. PEDF may act protectively against aVSP, and serve as a negative biomarker and a target for drug discovery for aVSP.

目的脑血管痉挛仍然是动脉瘤性蛛网膜下腔出血(SAH)后延迟性脑缺血(DCI)和不良预后的主要决定因素。本研究旨在探讨一种母细胞蛋白色素上皮衍生因子(PEDF)是否可以作为SAH术后血管痉挛(aVSP)的生物标志物。方法在197例动脉瘤性SAH连续患者中,连续测定SAH术后第1-12天的血浆PEDF浓度。结果与未破裂的脑动脉瘤患者相比,SAH 患者的血浆 PEDF 浓度升高,尤其是世界神经外科医师联合会(WFNS)IV-V 级患者的血浆 PEDF 浓度更高。然而,第1-3天和第10-12天血浆PEDF浓度较高与未发生aVSP有关。在一项仅限于72例术前WFNS分级为I-III级的非镇静患者的分析中,血浆PEDF浓度在既无DCI也无aVSP的患者中也显著较高。多变量分析表明,第1-3天血浆PEDF浓度升高是不发生aVSP的独立预测因素。结论这是第一项测量SAH患者血浆PEDF浓度并显示其与aVSP发生关系的研究。PEDF 可能对 aVSP 起保护作用,并可作为一种阴性生物标志物和 aVSP 药物开发的靶点。
{"title":"Increased plasma pigment epithelium-derived factor (PEDF) concentrations as a negative predictor of angiographic vasospasm after aneurysmal subarachnoid hemorrhage","authors":"","doi":"10.1016/j.hest.2024.02.001","DOIUrl":"10.1016/j.hest.2024.02.001","url":null,"abstract":"<div><h3>Objective</h3><p>Cerebral vasospasm remains a major determinant of delayed cerebral ischemia (DCI) and poor outcomes after aneurysmal subarachnoid hemorrhage (SAH). This study was aimed to investigate if a matricellular protein pigment epithelium-derived factor (PEDF) can be a biomarker of angiographic vasospasm (aVSP) after SAH.</p></div><div><h3>Methods</h3><p>In 197 consecutive patients with aneurysmal SAH, plasma PEDF concentrations were serially measured at days 1–12 post-SAH.</p></div><div><h3>Results</h3><p>Plasma PEDF concentrations in SAH patients were elevated compared with patients with unruptured cerebral aneurysms, and especially higher in patients with admission World Federation of Neurological Surgeons (WFNS) grades IV–V. However, higher plasma PEDF concentrations at days 1–3 and 10–12 were associated with no development of aVSP. In an analysis limited to 72 non-sedated patients with preoperative WFNS grades I–III, plasma PEDF concentrations were also significantly higher in patients with neither DCI nor aVSP. Multivariate analysis showed that increased plasma PEDF concentration at days 1–3 was an independent predictor of no development of aVSP.</p></div><div><h3>Conclusion</h3><p>This was the first study to measure plasma PEDF concentrations and to show the relationships with aVSP development in SAH patients. PEDF may act protectively against aVSP, and serve as a negative biomarker and a target for drug discovery for aVSP.</p></div>","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 4","pages":"Pages 169-176"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589238X24000147/pdfft?md5=886bf25ddd8a2763e2546c402cad65f7&pid=1-s2.0-S2589238X24000147-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139892945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum Regarding Previously Published Articles 关于以前发表的文章的更正
IF 1.3 Q4 CLINICAL NEUROLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.hest.2023.11.009
{"title":"Corrigendum Regarding Previously Published Articles","authors":"","doi":"10.1016/j.hest.2023.11.009","DOIUrl":"10.1016/j.hest.2023.11.009","url":null,"abstract":"","PeriodicalId":33969,"journal":{"name":"Brain Hemorrhages","volume":"5 4","pages":"Page 204"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589238X23000608/pdfft?md5=098869fa876c226ab20f83c422795141&pid=1-s2.0-S2589238X23000608-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138625438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brain Hemorrhages
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1